dc.contributor.author | Kingston, B | |
dc.contributor.author | Pearson, A | |
dc.contributor.author | Turner, N | |
dc.date.accessioned | 2019-11-06T10:26:41Z | |
dc.identifier.citation | JCO Precision Oncology journal | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/3403 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.title | Exceptional Response to AKT inhibition in breast cancer patients with germline PTEN mutations | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2019-10-03 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2019-10-03 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | JCO Precision Oncology journal | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Molecular Oncology | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Molecular Oncology | |
pubs.publication-status | Accepted | |
pubs.embargo.terms | Not known | |
icr.researchteam | Molecular Oncology | |
dc.contributor.icrauthor | Kingston, Belinda | |
dc.contributor.icrauthor | Turner, Nicholas | |